Post-Brexit update from house builders Telford and Countryside
Updates are also expected from Tissue Regenix, Diurnal Group and Marston's
Company
LON:TRX
Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.
255 stories · page 11 of 13
Updates are also expected from Tissue Regenix, Diurnal Group and Marston's
Investments and investor services
The market was encouraged by Tissue Regenix with the stock advancing 16% over the last five trading days.
Epistem formally changes its name, a double dose of good news for Tissue Regenix and Sound Energy's Tendrara project 'above expectations'.
Tissue Regenix agrees a three-year contract; Plexus Holding chief buys £200,000 worth of shares; Condor Gold identifies a potential gold-bearing corridor; and much more…
Main share price risers and fallers in London at 4.15pm
The medtech firm's products leave a so-called 'scaffold' which can then be used to repair wounded body parts
The think tank - the Organisation for Economic Co-operation and Development (OECD) - cut its forecast for UK growth this year to 1.7%..
Deltex Medical Group has hailed the “superb results”, Tissue Regenix beefs up its board and MySQUAR updates on the success of its first game.
The top flight dropped 65 points to 6,165 and in small-cap land the FTSE AIM 100 eased 0.5% to 3,470.
Professor Homer-Vanniasinkam is regularly invited to lecture at prestigious establishments across the world
Investments and investor services
The top flight dropped 39.92 points to 6190.87 after an ICM phone poll showed Leave taking the lead
The firm's technology removes cellular material leaving a 'scaffold' which can then be used to repair diseased or worn out body parts
The firm's technology removes cellular material from animal and human tissue leaving a 'scaffold' which can then be used to repair diseased or worn out body parts.
Archive
Scribes at Barclays give credit to the timing and strategy of First Quantum Minerals Ltd today and repeat an 'overweight' rating...
Metal Tiger plc shares shot up 25% as it told investors its transaction to invest in ZimNRG had been approved by shareholders .
Regenerative medtech Tissue Regenix Group PLC is making clear progress on all fronts, said heavyweight US broker Jefferies today, which rates the shares a 'buy'.